Click here to see a Remi-d Flash Presentation

 

Remi-d would address many of the issues facing X-ray deployment in developing countries. Some of these hurdles include:

 

Hurdle #1
Poor infrastructure requiring renovations to existing facilities or the building of new ones creates a cost barrier to the timely and efficient deployment of imaging equipment. 

Device Remedy
Self-contained nature of the Device eliminates the need for renovations and enables digital X-ray capabilities to be brought to virtually any facility.

 

Hurdle #2
Developing countries are faced with a lack of skilled medical personnel available for both taking and interpreting chest X-rays.

Device Remedy
Remote technologist operating the X-ray system and remote radiologist interpreting the film eliminate the need to have this expertise onsite.  The Device leverages technology to deploy these critical skill sets over large geographic areas and distances. 

 

Hurdle #3
Data regarding TB screening needs to be much more effectively stored and transmitted.

Device Remedy
The electronic capture of patient information allows for a central repository of patient data as well as the dissemination and sharing of that data across stakeholders (patient, physician, local health authorities, national health authorities, WHO and others).

 

*NOTE:  Remi-d has not yet been submitted for approval to the FDA.  There are significant risks and uncertainties in product research and development.  Scientific and regulatory hurdles may cause the project to be discontinued or delayed or fail to reach the market.  There can be no guarantee that Remi-d will receive regulatory approval, or that it will be commercially successful. 

 

Back to WHITIA's Homepage